All Stories

  1. The Potential Clinical Properties of Magnesium
  2. Recent Advances on Iron(III) Selective Fluorescent Probes with Possible Applications in Bioimaging
  3. A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead
  4. Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology
  5. Complex formation equilibria of polyamine ligands with copper(II) and zinc(II)
  6. The essential metals for humans: A brief overview
  7. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays
  8. 3. Iron Chelation for Iron Overload in Thalassemia
  9. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation
  10. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+
  11. Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips
  12. Looking at new ligands for chelation therapy
  13. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies
  14. para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite
  15. Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine
  16. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions
  17. Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan
  18. Toxicity of Nanoparticles: Etiology and Mechanisms
  19. Chemical features of in use and in progress chelators for iron overload
  20. Silver coordination compounds: A new horizon in medicine
  21. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds
  22. Substituent effects on ionization constants as a predictive tool of coordinating ability
  23. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one
  24. Metal Ion Toxicity
  25. Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic
  26. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators
  27. A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions
  28. An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions
  29. Preface
  30. Noble metals in medicine: Latest advances
  31. Kill or cure: Misuse of chelation therapy for human diseases
  32. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity
  33. Iron chelating agents for iron overload diseases
  34. Editorial (Thematic Issue: The State of Art in the Treatment of Metal Toxicity)
  35. Searching for new aluminium chelating agents: A family of hydroxypyrone ligands
  36. IronIII and aluminiumIII complexes with substituted salicyl-aldehydes and salicylic acids
  37. Nickel binding sites in histone proteins: Spectroscopic and structural characterization
  38. A family of hydroxypyrone ligands designed and synthesized as iron chelators
  39. Metal Ions in the Pathogenesis of Alzheimer’s Disease: An Open Field
  40. Chelation Therapy for Metal Intoxication: Comments from a Thermodynamic Viewpoint
  41. ChemInform Abstract: Iron(III) Selective Molecular and Supramolecular Fluorescent Probes
  42. Complex formation equilibria of CuIIand ZnIIwith triethylenetetramine and its mono- and di-acetyl metabolites
  43. Manganese and cobalt binding in a multi-histidinic fragment
  44. The meaning of aluminium exposure on human health and aluminium-related diseases
  45. Different approaches to the study of chelating agents for iron and aluminium overload pathologies
  46. Chelating Agents for Metal Intoxication
  47. Iron(iii) selective molecular and supramolecular fluorescent probes
  48. Copper uptake and trafficking in the brain
  49. Aluminium-dependent human diseases and chelating properties of aluminium chelators for biomedical applications
  50. Preface
  51. Chelating agents for human diseases related to aluminium overload
  52. Thermodynamic remarks on chelating ligands for aluminium related diseases
  53. ChemInform Abstract: Human Diseases Related to Aluminum Overload
  54. Human diseases related to aluminium overload
  55. Kojic acid derivatives as powerful chelators for iron(iii) and aluminium(iii)
  56. Chemical equilibria in wastewaters during toxic metal ion removal by agricultural biomass
  57. ChemInform Abstract: Iron Chelating Agents in Clinical Practice
  58. Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives
  59. Copper-related diseases: From chemistry to molecular pathology
  60. Interaction between aspergillic acid and iron(III): A potentiometric, UV–Vis, 1H NMR and quantum chemical study
  61. Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators
  62. Towards a new attenuating compound: A potentiometric, spectrophotometric and NMR equilibrium study on Fe(III), Al(III) and a new tetradentate mixed bisphosphonate–hydroxypyridinonate ligand
  63. Iron chelating agents for the treatment of iron overload
  64. Preface to the special issue on the “XVIII Italian–Spanish Congress on the Thermodynamics of Metal Complexes (ISMEC 2007)”
  65. Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone
  66. Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates
  67. Enhancement of γ-Aminobutyric Acid Binding by Quazepam, a Benzodiazepine Derivative with Preferential Affinity for Type I Benzodiazepine Receptors
  68. A Windmill-Shaped Hexacopper(II) Molecule Built Up by Template Core-Controlled Expansion of Diaquatetrakis(μ 2 -adeninato- N 3, N 9)dicopper(II) with Aqua(oxydiacetato)copper(II)
  69. Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)]n, [Cu(tda)(Him)2(H2O)] and [Cu(tda)(5Mphen)]·2H2O (Him=imidazole, 5Mphen=5-methyl-1,10-phenanthroline)
  70. Structural correlations in nickel(II)–thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)3]
  71. Foreword : To the memory of Professor D. De Filippo
  72. Evaluation of a Fibre Optic Device in Solution Equilibria Studies. Application to 3-Hydroxybenzoic Acid Ionization
  73. Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues
  74. Equilibrium study on Cd(II) and Zn(II) chelates of mercapto carboxylic acids
  75. Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenolsA potentiometric, spectrophotometric and 13C NMR study
  76. Spectrophotometric and potentiometric study on iron(II) complexes with some macrocyclic ligands
  77. Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease
  78. Spectrophotometric and potentiometric study on platinum(II) chelates of mercapto carboxylic acids
  79. Renal Copper Content and Distribution in Wilson's Disease
  80. Oral iron chelators for clinical use
  81. Equilibrium study on Pd(II) chelates of mercapto carboxylic acids
  82. Iron chelating agents in clinical practice
  83. Spectrophotometric methods in the study of solution equilibria
  84. Structure optimization in a series of acid dyes for wool and nylon
  85. Characterization of the ionization and spectral properties of mercapto-carboxylic acids Correlation with substituents and structural features
  86. Chapter 15 Least-squares estimation of parameters affecting nmr line-shapes in multi-site chemical exchange
  87. Chemometric Methods Applied to an ICP-AES Study of Chemical Element Distributions in Autopsy Livers from Subjects Affected by Wilson and β- Thalassemia
  88. Simultaneous decomposition of several spectra into the constituent Gaussian peaks
  89. Uneven hepatic iron and phosphorus distribution in beta-thalassemia
  90. Characterization of the ionization and spectral properties of sulfonephthalein indicators. Correlation with substituent effects and structural features. Part II
  91. A potentiometric, spectrophotometric and 1H NMR study on the interaction of cimetidine, famotidine and ranitidine with platinum(II) and palladium(II) metal ions
  92. Uneven hepatic copper distribution in Wilson's disease
  93. Study of the copper(II)-Aztreonam™ system by potentiometry and spectrophotometry, and structural characterization by 13C NMR relaxation
  94. Characterization of the ionization and spectral properties of sulfonephthalein indicators. Correlation with substituent effects and structural features
  95. REACTION BETWEEN [PdCl4]2-AND 5,5-DIMETHYL-2-THIOXOIMIDAZOLIDIN-4-ONE
  96. A multinuclear NMR study on the microscopic ionization constants of adenosine-5′-triphosphate in aqueous solution
  97. Reliability of the parameters in the resolution of overlapped Gaussian peaks
  98. Synthesis and characterization of iron derivatives of dihydrolipoic acid and dihydrolipoamide
  99. Synthesis and characterization of metal derivatives of dihydrolipoic acid and dihydrolipoamide
  100. An 1H NMR and potentiometric study of the interaction between platinum(II) and cimetidine
  101. An investigation on the interaction between palladium(II) and L-citrulline by 1H and 13C NMR spectroscopy and potentiometry
  102. 1H and 13C NMR studies of (phenylethynyl) (triphenylphosphine) gold(I)
  103. An approach to obtaining an optimal design in the non-linear least squares determination of binding parameters in a complex biochemical system
  104. Potentiometric and 13C NMR study of the interaction between boric acid and pyrogallol (1,2,3-trihydroxybenzene)
  105. A BASIC program for least-squares estimation of the parameters influencing line shapes in multi-site chemical exchange in nuclear magnetic resonance spectrometry
  106. Constants of 1:1 complexes from NMR or spectrophotometric measurements
  107. Determination of ionization constants of a polyprotic acid with use of least-squares methods
  108. An X-ray and NMR Study on Cerium(III) and Magnesium(II) Perchlorate Solutions
  109. A BASIC computer program for the determination of binding parameters in a complex system
  110. Mechanism of the reaction of iron(III) dithiocarbamates with iodine
  111. Association constants of 1:1 and 2:1 molecular complexes from spectrophotometric data; experimental design and reliability of the parameters
  112. Computation of acidity constants of a polyprotic acid from nuclear magnetic resonance or u.v.-visible spectrophotometric data
  113. Study of the interactions of CdCl2 and Cd(ClO4)2 with adenosine-5′-triphosphate in aqueous solution by 1H, 13C, 31P, 113Cd, NMR spectroscopy and X-ray diffraction tecnique
  114. Reaction of bis(morpholinothiocarbonyl) disulphide with iodine. Existence of a 1 : 1 charge-transfer precursory adduct in an oxidation reaction. Isolation and crystal structure of bis[3,5-di(N-morpholinio)-1,2,4-trithiolane] hexadecaiodide
  115. Substituent effect on carbon-13 chemical shifts of 3-(para substituted benzoyl)-5-amino-1,2,4-oxadiazoles
  116. Changes in the characteristics of low affinity GABA binding sites elicited by Ro15-1788
  117. An 27Al and 13CN.M.R. study of the Complexes between Al3+ and Various Organic Molecules Containing the Amide Group in Concentrated Aqueous Solution
  118. Stress and β-carbolines decrease the density of low affinity gaba binding sites
  119. Evidence for an involvement of GABA receptors in the mediation of the proconvulsant action of ethyl-β-carboline-3-carboxylate
  120. Adduct formation of some tris(N,N dialkyldithiocarbamato)Cr(III) complexes with iodine
  121. 1H and 31P NMR study of the complexes between Cd(II) and adenosine-5′-triphosphate
  122. A study on the binding of diazepam to serum albumins by T1 NMR measurements
  123. An 27Al NMR study of complexes between Al3+ and imidazolidine-2-one in concentrated aqueous solution
  124. Reaction of bis (morpholinoselenocarbonyl) triselenide with iodine. Existence of a 1 : 1 charge-transfer precursory adduct in solution in an oxidative reaction. Isolation and crystal structure of the new (N-morphoilnecarbodiselenoato)selenium(II)iodide
  125. Adduct formation of tris(morpholine-4-carbo-dithio- or diselenoato)Co(III) complexes with iodine
  126. Equilibrium constants of the Fe(III)dopamine system in aqueous solution
  127. C-13 magnetic relaxation rates and H-1 and C-13 paramagnetic shifts of Co(II) complex of dopamine
  128. C-13 magnetic relaxation rates and H-1 and C-13 paramagnetic shifts of Ni(II) complex of dopamine
  129. Reliability of the association constants of 1:1 molecular complexes from NMR data
  130. An analysis of errors in estimating association constants and molar extinction coefficients from spectrophotometric data for 1 : 1 molecular complexes. Application to literature data
  131. Reliability of association constants of 1:1 molecular complexes from spectrophotometric data